| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2364 | 2018 |
| The landscape of genomic alterations across childhood cancers SN Gröbner, BC Worst, J Weischenfeldt, I Buchhalter, K Kleinheinz, ... Nature 555 (7696), 321-327, 2018 | 1361 | 2018 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 1120 | 2015 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 848 | 2016 |
| Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy JH Schulte, S Lim, A Schramm, N Friedrichs, J Koster, R Versteeg, I Ora, ... Cancer research 69 (5), 2065-2071, 2009 | 536 | 2009 |
| Cancer screening recommendations for individuals with Li-Fraumeni syndrome CP Kratz, MI Achatz, L Brugieres, T Frebourg, JE Garber, MLC Greer, ... Clinical Cancer Research 23 (11), e38-e45, 2017 | 474 | 2017 |
| Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort SM Waszak, PA Northcott, I Buchhalter, GW Robinson, C Sutter, ... The Lancet Oncology 19 (6), 785-798, 2018 | 368 | 2018 |
| Sarcoma classification by DNA methylation profiling C Koelsche, D Schrimpf, D Stichel, M Sill, F Sahm, DE Reuss, M Blattner, ... Nature communications 12 (1), 498, 2021 | 331 | 2021 |
| The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, ... Acta neuropathologica 133, 5-12, 2017 | 320 | 2017 |
| Childhood cancer predisposition syndromes—a concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology T Ripperger, SS Bielack, A Borkhardt, IB Brecht, B Burkhardt, ... American journal of medical genetics Part A 173 (4), 1017-1037, 2017 | 307 | 2017 |
| Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas KW Pajtler, J Wen, M Sill, T Lin, W Orisme, B Tang, JM Hübner, ... Acta neuropathologica 136, 211-226, 2018 | 239 | 2018 |
| cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors DW Ellison, KD Aldape, D Capper, M Fouladi, MR Gilbert, RJ Gilbertson, ... Brain Pathology 30 (5), 863-866, 2020 | 228 | 2020 |
| Lysine-specific demethylase 1 restricts hematopoietic progenitor proliferation and is essential for terminal differentiation A Sprüssel, JH Schulte, S Weber, M Necke, K Händschke, T Thor, ... Leukemia 26 (9), 2039-2051, 2012 | 217 | 2012 |
| Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling SC Mack, KW Pajtler, L Chavez, K Okonechnikov, KC Bertrand, X Wang, ... Nature 553 (7686), 101-105, 2018 | 202 | 2018 |
| Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis V Ramaswamy, T Hielscher, SC Mack, A Lassaletta, T Lin, KW Pajtler, ... Journal of clinical oncology 34 (21), 2468-2477, 2016 | 196 | 2016 |
| Recommendations for cancer surveillance in individuals with RASopathies and other rare genetic conditions with increased cancer risk A Villani, MLC Greer, JM Kalish, A Nakagawara, KL Nathanson, ... Clinical Cancer Research 23 (12), e83-e90, 2017 | 159 | 2017 |
| The pediatric precision oncology INFORM registry: clinical outcome and benefit for patients with very high-evidence targets CM Van Tilburg, E Pfaff, KW Pajtler, KPS Langenberg, P Fiesel, BC Jones, ... Cancer discovery 11 (11), 2764-2779, 2021 | 155 | 2021 |
| High ALK Receptor Tyrosine Kinase Expression Supersedes ALK Mutation as a Determining Factor of an Unfavorable Phenotype in Primary Neuroblastoma JH Schulte, HS Bachmann, B Brockmeyer, K DePreter, A Oberthür, ... Clinical Cancer Research 17 (15), 5082-5092, 2011 | 135 | 2011 |
| Germline elongator mutations in sonic hedgehog medulloblastoma SM Waszak, GW Robinson, BL Gudenas, KS Smith, A Forget, M Kojic, ... Nature 580 (7803), 396-401, 2020 | 131 | 2020 |
| MYCN amplification drives an aggressive form of spinal ependymoma DR Ghasemi, M Sill, K Okonechnikov, A Korshunov, S Yip, PW Schutz, ... Acta neuropathologica 138, 1075-1089, 2019 | 130 | 2019 |
